Helping pharmaceutical, biotechnology and life sciences organizations navigate growth, innovation and transformation.
Mefaris Strategy Partners combines scientific expertise, strategic thinking and executive leadership experience to create sustainable value in complex healthcare environments.
Corporate strategy, growth opportunities, portfolio optimization and executive decision support.
Medical strategy, scientific engagement, launch readiness, evidence planning and capability building.
Strategic advisory across obesity, metabolic health, diabetes and cardiorenal-metabolic disease.
Real-world evidence, integrated evidence planning and innovative medical engagement models.
Organizational transformation, governance optimization and executive coaching.
Deep therapeutic expertise across obesity, cardiorenal-metabolic disease, cardiovascular medicine, oncology and metabolic health.
Extensive global Medical Affairs, product leadership, launch excellence and healthcare strategy experience across Europe, the Americas and Asia.
Delivering actionable recommendations and supporting successful implementation — turning strategy into measurable outcomes.
Long-term collaboration built on integrity, scientific rigor and measurable impact — treating clients as true partners.
The future of healthcare belongs to organizations that successfully combine scientific innovation, medical evidence and strategic execution.
— Dr. Markus Scheerer, Founder & Managing Director
We partner with organizations across the healthcare ecosystem to advance innovation and improve outcomes for patients worldwide.
Pharmaceutical executive and scientist with 15+ years at Bayer, AstraZeneca and Bristol Myers Squibb — spanning Medical Affairs, cardiorenal-metabolic medicine, oncology and evidence-based strategy across global markets.
"The future of healthcare will be shaped by organizations that successfully integrate scientific innovation, medical evidence and strategic execution."
READ MORE ›Pharmaceutical executive, scientist and strategic advisor with more than 15 years of international experience across Medical Affairs, evidence generation, healthcare innovation and product leadership at Bayer, AstraZeneca and Bristol Myers Squibb.
His scientific background — including extensive experience in cardiorenal-metabolic and oncology medicine — provides the foundation for rigorous, evidence-based strategic thinking that bridges science and business.
READ MORE ›Comprehensive strategic expertise across the healthcare value chain — tailored, science-driven and results-oriented.
Supporting pharmaceutical, biotech and life sciences organizations in developing and executing winning strategies in complex healthcare environments.
Building world-class Medical Affairs capabilities that drive scientific credibility, clinical adoption and evidence-based value communication.
Deep therapeutic expertise in obesity, metabolic health and cardiorenal-metabolic disease — one of the most dynamic areas of modern medicine.
Bridging clinical data generation and real-world healthcare decision-making through integrated, innovative evidence strategies.
Strategic advisory for oncology portfolios — drawing on deep scientific understanding and Medical Affairs experience across solid tumors and hematology.
Supporting organizations and leaders through transformation — building the capabilities and cultures needed for long-term healthcare success.
Deep dive into your organization's context, competitive environment, strategic challenges and specific goals.
Evidence-based, actionable recommendations tailored precisely to your situation — grounded in scientific rigor and practical feasibility.
Working alongside you to implement strategies, track outcomes and adapt in real time — turning plans into measurable impact.
We would love to understand your strategic challenges and explore how we can create value together.
We partner with organizations across the healthcare ecosystem to advance innovation and improve outcomes for patients worldwide.
Strategy across the pharmaceutical value chain from pipeline to commercial excellence.
Translating breakthrough science into sustainable business impact.
Strategic advice for medical technology organizations navigating complex healthcare markets.
Scientific and strategic due diligence for venture capital and private equity in healthcare.
Building strategic foundations for emerging healthcare companies.
Commercial strategy and positioning for CROs and specialty consultancies.
Science meets strategy — meet the founder and managing director of Mefaris Strategy Partners.
Dr. Markus Scheerer is a pharmaceutical executive, scientist and strategic advisor with more than 15 years of international experience spanning Medical Affairs, evidence generation, healthcare innovation and product leadership. He has held senior positions at Bayer, AstraZeneca and Bristol Myers Squibb, working across global markets in Europe, the Americas and Asia.
His scientific background in cardiorenal-metabolic medicine and oncology — including deep expertise from drug development programs in heart failure, chronic kidney disease and metabolic disease — provides the foundation for rigorous, evidence-based strategic thinking that bridges the worlds of science and business.
Full career details available on LinkedIn →
"The future of healthcare will be shaped by organizations that successfully integrate scientific innovation, medical evidence and strategic execution."
— Dr. Markus Scheerer, PhD, MBAReady to explore how Mefaris Strategy Partners can support your organization? We look forward to hearing from you.
Mefaris Strategy Partners UG (haftungsbeschränkt)
Lindenstraße 8
82166 Gräfelfing (Munich Area)
Germany
Dr. Markus Scheerer, PhD, MBA
We typically respond to all inquiries within 24 business hours.
"The best partnerships begin with an honest conversation about the challenge at hand."
— Dr. Markus Scheerer
Mefaris Strategy Partners UG (haftungsbeschränkt)
Lindenstraße 8
82166 Gräfelfing, Germany
Managing Director: Dr. Markus Scheerer, PhD, MBA
Email: scheerer@mefaris.com
Registered in the Commercial Register.
Registration Court: Amtsgericht München
Registration Number: HRB 313153
VAT ID pursuant to § 27a UStG: [Please enter your VAT ID]
Dr. Markus Scheerer
Lindenstraße 8, 82166 Gräfelfing, Germany
Liability for Content: As a service provider, we are responsible for our own content on these pages in accordance with general laws (§ 7 TMG). We are not obligated to monitor transmitted or stored third-party information.
Liability for Links: Our offer contains links to external websites of third parties, on whose contents we have no influence. The respective provider is responsible for the content of the linked pages.
Copyright: Content and works created by the site operators are subject to German copyright law. Reproduction requires prior written consent.
Mefaris Strategy Partners UG (haftungsbeschränkt)
Dr. Markus Scheerer, PhD, MBA
Lindenstraße 8, 82166 Gräfelfing, Germany
Email: scheerer@mefaris.com
Contact Form: Data from the inquiry form is stored solely for processing your inquiry and potential follow-up questions. Data is not shared without consent.
Server Log Files: The provider automatically collects standard server log data transmitted by your browser.
You have the right to information, correction and deletion of your personal data at any time. Please contact: scheerer@mefaris.com